Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2021 | Liquid biopsy: Role of the advocacy for lung cancer

Amy Moore • 18 Oct 2021
ISLB 2021
Lung Cancer

Amy Moore, PhD, LUNGevity Foundation, San Carlos, CA, explains the role of patient advocacy in lung cancer, specifically in relation to liquid biopsy and genomic profiling. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

More from Amy Moore

2:39
Current challenges for lung cancer patients due to COVID-19
Amy Moore • 24 Oct 2022
1:58
Unmet needs in lung cancer from a patient perspective
Amy Moore • 24 Oct 2022
4:46
Challenges to be overcome in liquid biopsy
Amy Moore • 24 Oct 2022
3:35
Impact of COVID-19 on lung cancer diagnosis and treatment
Amy Moore • 18 Oct 2021

Related Videos

0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals